4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0001193125-26-025302
SVP, Finance & Accounting sold 7,142 shares at $8.46 ($60,426)
From the SEC's structured data for this filing
Trades in this filing
DOYLE THOMAS JAMES · SVP, Finance & Accounting
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-27 | Sale : show line 1 in the form | −2,226 | $8.46 | $18,834 | 150,083 | D |
| 2026-01-27 | Sale : show line 2 in the form | −1,114 | $8.46 | $9,425 | 148,969 | D |
| 2026-01-27 | Sale : show line 3 in the form | −695 | $8.46 | $5,880 | 148,274 | D |
| 2026-01-27 | Sale : show line 4 in the form | −2,226 | $8.46 | $18,834 | 146,048 | D |
| 2026-01-27 | Sale : show line 5 in the form | −881 | $8.46 | $7,454 | 145,167 | D |
| Open-market sales · 7,142 sh · avg $8.46 · $60,426 | ||||||
Loading xslF345X05/ownership.xml…